Diabetes and Combined Lipid Therapy Regimen - DIACOR

Description:

The goal of the trial was to evaluate treatment with simvastatin, fenofibrate, or a combination of simvastatin and fenofibrate among patients with type II diabetes and mixed dyslipidemia.